Female Sexual Dysfunction Clinical Trial
Official title:
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
Many women will likely experience a sexual problem in their lifetimes. The Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE) study surveyed more than 30,000 U.S. women aged >18 years regarding sexual function. Results from this study estimated that 12% of women experience a diagnosable sexual disorder that causes personal distress, with lack of sexual desire being the most prevalent. - See more at: http://www.uspharmacist.com/content/d/featured_articles/c/56908/#sthash.LTDkyRlR.dpuf
Standard of care includes completion of a sexual dysfunctional questionnaire at every visit.
This study will collect information from the questionnaires and office visit and follow the
patient for outcomes of successful or non successful treatment.
The purpose of this study is to collect and analyze data on the characteristics of women who
present with sexual dysfunction, to evaluate what risk factors contribute to sexual
dysfunction and to evaluate what factors contribute to successful treatment of sexual
dysfunction.
Upon a visit to the office participants will complete the Female Sexual Function Index
(FSFI), this is standard of care for all patients. Research related procedures include:
Review of questionnaires and collecting data from medical records regarding medical history,
and treatment outcomes. If a participant does not return to the office for a follow up visit
(or final visit) the final questionnaire will be sent by their preference (e-mail, phone, or
mail) noted in the consent form.
Participates will also be given the option of participating in a "future storage of data".
Future testing will be in the area of female sexual dysfunction. Data will be identified by
a code number and only the research staff at Saint Louis University will have access to the
data.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05806424 -
Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
|
||
| Completed |
NCT01364623 -
PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women
|
Phase 1 | |
| Completed |
NCT06060691 -
the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction
|
Phase 1 | |
| Recruiting |
NCT04419961 -
Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester
|
N/A | |
| Completed |
NCT04122703 -
Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction
|
N/A | |
| Recruiting |
NCT03498443 -
Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
|
||
| Completed |
NCT03232801 -
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
|
N/A | |
| Completed |
NCT04124640 -
Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
|
||
| Completed |
NCT00995072 -
Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function
|
N/A | |
| Active, not recruiting |
NCT05168371 -
Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction
|
N/A | |
| Completed |
NCT04384172 -
Effect of Peripheral Neuromodulation on Vaginal Blood Flow
|
N/A | |
| Recruiting |
NCT06237166 -
Evaluation of an Online Intervention for Female Sexual Dysfunction
|
N/A | |
| Completed |
NCT03463707 -
BP101 for Adults With Female Sexual Dysfunction
|
Phase 3 | |
| Recruiting |
NCT01078077 -
The Impact of a Topical Vasodilating Cream on Female Sexual Experience
|
N/A | |
| Completed |
NCT02229721 -
Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT01724658 -
Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women
|
Phase 2 | |
| Completed |
NCT00479570 -
Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.
|
Phase 2 | |
| Not yet recruiting |
NCT06116045 -
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
|
Phase 2 | |
| Completed |
NCT01195701 -
Clitoral Location in Relation to Sexual Function Using Pelvic Imaging
|
N/A | |
| Completed |
NCT04484753 -
Validation of iPelvis App for Female Pelvic Floor Dysfunction
|
N/A |